Schroll Medical ApS: Financial statements 2022
CVR: 39467135
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Schroll Medical ApS (CVR 39467135) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 20,214,838 and a net result of DKK -3,108,269 compared with DKK -5,230,802 the year before. Equity in the 2022 report amounted to DKK 69,490,706. The solvency ratio was 77.4%. The company had 36 employees in the financial year.
- Gross Profit
- DKK 20,214,838
- Profit/Loss
- DKK -3,108,269
- Equity
- DKK 69,490,706
- Total Assets
- DKK 89,746,869
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 20.2M | -3.1M | 69.5M | 36 |
| 2021 | - | -187K | -5.2M | 52.6M | 34 |
| 2020 | - | -31K | -2M | 27.8M | 25 |
Official annual report
Keep an eye on Schroll Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Schroll Medical ApS has published its annual report for 2021. Gross profit came to DKK -186,808, and the net result was DKK -5,230,802.
About Schroll Medical ApS
Schroll Medical ApS is a Danish company of the type Anpartsselskab based in Årslev, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Carsten Garbo Schroll. The board consists of Søren Dolleris Schroll (chair), Carsten Garbo Schroll, Mariolla Pernille Damborg Dolleris Schroll and Stine Garbo Schroll. The company is owned by Schroll Medical Holding ApS. The company has 107 employees (2026). In 2025, the company reported a gross profit of DKK 98,362,345 and a net result of DKK 40,261,512 compared with DKK 7,271,419 the year before. Equity in the 2025 report amounted to DKK 119,466,113.